Osaterone

Showing 3 of 3 results
Osaterone is used primarily to manage benign prostatic hyperplasia (BPH) in dogs. Read more

Osaterone is used primarily to manage benign prostatic hyperplasia (BPH) in dogs.

Essential insights

  • Androgen receptor antagonism: Osaterone acts as an antagonist at androgen receptors in the prostate gland.
  • Reduction of prostate size: By blocking these receptors, osaterone inhibits the effects of androgens that contribute to prostate enlargement.
  • Alleviation of symptoms: This action leads to a reduction in prostate size and alleviates symptoms associated with BPH, such as difficulty urinating.

Products

Dog icon
Ypozane (3 - 7.5 kg)

Ypozane (3 - 7.5 kg)

1,875 mg Tablet (Blister pack)
1 x 7 pc
Dog icon
Ypozane (7.5 - 15 kg)

Ypozane (7.5 - 15 kg)

3,75 mg Tablet (Blister pack)
1 x 7 pc
Dog icon
Ypozane (30 - 60 kg)

Ypozane (30 - 60 kg)

15 mg Tablet (Blister pack)
1 x 7 pc
VETiSearch™ ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - VAT Number: 39926679
VETiSearch.co.uk Copyright © 2026. All rights reserved. VETiSearch contains information on veterinary medicinal products authorised for marketing in the United Kingdom and is intended for veterinary professionals. The information is used at your own risk. VETiSearch disclaims all liability for errors, omissions and lack of updates, as well as for any loss or damage that may arise from the use of the information.